Clear Search sequence regions


  • adults (2)
  • alcl3 (2)
  • alkyl (2)
  • amine (8)
  • bibenzyl (7)
  • brain (7)
  • carbon (9)
  • central nervous system (1)
  • china (2)
  • city (1)
  • cognition (2)
  • compound 24 (1)
  • compounds biphenyl (1)
  • contains (1)
  • crystal (1)
  • dementia (2)
  • diphenyl (1)
  • diphenyl (18)
  • dntb (1)
  • donepezil (5)
  • ethanol (1)
  • gold (1)
  • hydrogen bonds (1)
  • hydrolysis (1)
  • hydroxyl (1)
  • ice (1)
  • inhibit (6)
  • inhibitor enzymes (1)
  • iso ompa (2)
  • isomers (2)
  • japan (1)
  • mass (2)
  • meso (1)
  • methanol (1)
  • normal values (1)
  • p 113 (1)
  • patients (2)
  • PDB (2)
  • phosphate (1)
  • reagent (1)
  • receptor (1)
  • research (1)
  • rodent (1)
  • screen (1)
  • serum (2)
  • sodium (2)
  • solvents (2)
  • tau protein (1)
  • Sizes of these terms reflect their relevance to your search.

    Alzheimer's disease (AD), the most common form of dementia in adults, is a progressive neurodegenerative disorder of the brain characterized by loss of memory and steady deterioration of cognition. Here, a series of symmetrical molecules containing biphenyl/bibenzyl scaffolds (12-36) were designed, synthesized, and evaluated for their ability to inhibit both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). A biological evaluation showed that most of these biphenyl derivatives were potent AChE and BuChE inhibitors. Among them, compound 15 displayed the greatest ability to inhibit BuChE (IC50 = 0.74 µM) and was also a good AChE inhibitor (IC50 = 1.18 µM). Compound 19 was not only a potent AChE inhibitor (IC50 = 0.096 µM), but also a mild BuChE inhibitor (IC50 =1.25 µM). Overall, these results suggested that compound 19 may be a promising agent in the treatment of AD.

    Citation

    Dong-Mei Wang, Bo Feng, Hui Fu, Ai-Lin Liu, Lin Wang, Guan-Hua Du, Song Wu. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase. Molecules (Basel, Switzerland). 2017 Jan 20;22(1)

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28117700

    View Full Text